DOH Steering Committee for the Clinical Trials for COVID-19
The National Steering Committee for the conduct of clinical trials for investigational therapies for COVID-19 is a body that was created by virtue of DPO 2020-1377 to ensure the necessary oversight in the screening and administration of the investigational therapies for COVID-19 patients and ensure their safety and well-being.
News and updates regarding on the DOH Steering Committee for the Clinical Trials for COVID-19
COVID 19 Related Researches and Clinical Trials Related Posts DOH Steering Committee for the Clinical Trials for COVID-19 07 Oct 2020 cOvid 19 Updates 16 Nov 2020 Philippine Standard time
Department Memorandum 2021-0171 Related Posts cOvid 19 Updates 16 Nov 2020 DOH Steering Committee for the Clinical Trials for COVID-19 07 Oct 2020 Policy Dialogue on Universal Healthcare and Access
Undersecrertary Maria Rosario Vergeire of the Health Regulation Team presided the 8th meeting via Zoom. Once again, the latest status of the WHO Solidarity trials for COVID-19 treatments and vaccines
Today, the DOH Steering Committee for the Conduct of Clinical Trials for investigational treatment for COVID-19 convenes to discuss updates regarding the clinical trials for investigational products (IPs) for COVID-19.
Telephone Number: 02-8757734 Loc. 253
Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City
Email Address: firstname.lastname@example.org